47 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34405891 | Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK/STAT3 signaling pathway. | 2022 Apr | 1 |
2 | 35437787 | Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity. | 2022 May | 1 |
3 | 35440807 | Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21. | 2022 Apr 19 | 2 |
4 | 34116927 | Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway. | 2021 Dec | 2 |
5 | 31778258 | Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden. | 2020 Jan | 1 |
6 | 31901301 | Retraction notice to "STAT3-dependent TXNDC17 expression mediates Taxol resistance through inducing autophagy in human colorectal cancer cells" [GENE 584 (1) (2016) 75-82]. | 2020 Mar 10 | 1 |
7 | 32080166 | ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy. | 2020 Feb 20 | 1 |
8 | 32401925 | Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. | 2020 | 1 |
9 | 32705214 | A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells. | 2020 Sep | 4 |
10 | 33023532 | TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. | 2020 Oct 6 | 1 |
11 | 30431082 | ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel. | 2019 Jan | 3 |
12 | 30622051 | MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells. | 2019 Feb | 1 |
13 | 30866697 | Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells. | 2019 | 1 |
14 | 31077613 | Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer. | 2019 Sep | 10 |
15 | 31197964 | Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids. | 2019 Aug | 1 |
16 | 29324735 | Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429. | 2018 Jan 11 | 1 |
17 | 29565447 | CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway. | 2018 May | 1 |
18 | 29914005 | Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1. | 2018 | 2 |
19 | 27435393 | Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder. | 2017 Jan 15 | 2 |
20 | 28178652 | STAT3 is required for MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis in breast cancer cells. | 2017 Feb 28 | 2 |
21 | 28350087 | Paclitaxel induces apoptosis of esophageal squamous cell carcinoma cells by downregulating STAT3 phosphorylation at Ser727. | 2017 Apr | 6 |
22 | 28440494 | Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. | 2017 Jun | 1 |
23 | 28946186 | Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway. | 2017 Nov | 3 |
24 | 29072615 | The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells. | 2017 Oct 26 | 1 |
25 | 26878391 | MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. | 2016 Feb 15 | 2 |
26 | 26976343 | RETRACTED: STAT3-dependent TXNDC17 expression mediates Taxol resistance through inducing autophagy in human colorectal cancer cells. | 2016 Jun 10 | 2 |
27 | 27159676 | MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. | 2016 May 9 | 1 |
28 | 27779649 | Effect of curcumin and paclitaxel on breast carcinogenesis. | 2016 Dec | 1 |
29 | 27845771 | The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression. | 2016 Nov 15 | 2 |
30 | 25544427 | Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells. | 2015 Mar | 3 |
31 | 26360705 | Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells. | 2015 Nov | 1 |
32 | 24167124 | Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy. | 2014 Sep | 1 |
33 | 24525192 | Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. | 2014 Apr 25 | 1 |
34 | 24886434 | Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. | 2014 May 6 | 4 |
35 | 22723956 | miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. | 2012 | 2 |
36 | 22847181 | Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cells. | 2012 Nov | 7 |
37 | 22904633 | PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. | 2012 | 1 |
38 | 21949561 | STAT3 Inhibition by Microtubule-Targeted Drugs: Dual Molecular Effects of Chemotherapeutic Agents. | 2011 Jan 1 | 8 |
39 | 20113523 | MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. | 2010 Jan 31 | 3 |
40 | 20113836 | Role of STAT3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells. | 2010 Feb | 1 |
41 | 20693278 | Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling. | 2010 Nov | 5 |
42 | 21122157 | Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. | 2010 Dec 2 | 1 |
43 | 18587580 | CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. | 2009 Mar | 1 |
44 | 19372587 | ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells. | 2009 Apr | 3 |
45 | 19491198 | Reciprocal effects of STAT5 and STAT3 in breast cancer. | 2009 Jun | 1 |
46 | 19623660 | Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. | 2009 Nov 1 | 1 |
47 | 16951221 | Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. | 2006 Sep 1 | 3 |